Literature DB >> 18159423

Reasons for testing women for genital Chlamydia trachomatis infection in the Calgary region.

Deirdre L Church1, Ali Zentner, Heather Semeniuk, Elizabeth Henderson, Ron Read.   

Abstract

OBJECTIVE: To determine the clinical reason(s) for screening women with varying degrees of risk for genital Chlamydia trachomatis (CT) in the Calgary region.
DESIGN: Women aged 15 to 75 years were enrolled at various patient care locations. Pertinent risk factors for genital CT infection were recorded and a gynecological examination was performed. Two endocervical swabs and a first-void urine sample were collected for CT detection using two different nucleic acid amplification test methods.
SETTING: Calgary is an urban region that provides healthcare services to a population of almost one million people. Microbiology services are provided by Calgary Laboratory Services through a centralized regional laboratory service. MAIN
RESULTS: 504 women with a mean age of 28.1 +/-SD 8.22 years were enrolled. Two hundred ninety-one women (57.8%) were at high risk for acquiring genital CT infection. Twenty-eight (5.6%) tested positive for CT infection and almost all of these women (26 of 28, 93%) had risk factors for acquiring infection. Of the high-risk women, 9.8% were CT positive versus only 1.3% of women at low risk (P=0.0001). Only two of 152 (1.3%) women older than 30 years had genital CT infections. Although most women were asymptomatic, those with laboratory-confirmed CT infection were more likely to have genitourinary symptoms. Three hundred forty-three of 476 (72%) women who did not have genital CT infection had no risk factors, and screening was done as part of a routine gynecological examination for other purposes (prenatal visit, Pap smear).
CONCLUSION: Women without risk factors are being screened routinely for genital CT infection as part of a routine gynecological examination done for other reasons. Elimination of the routine screening of low-risk women older than 30 years of age would decrease the current regional utilization of CT tests by as much as one-third.

Entities:  

Keywords:  Women; Chlaymdia trachomatis; Genital infection; Screening

Year:  2003        PMID: 18159423      PMCID: PMC2094905          DOI: 10.1155/2003/682345

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  19 in total

1.  Chlamydial infection in Canada.

Authors: 
Journal:  CMAJ       Date:  1992-09-15       Impact factor: 8.262

Review 2.  A review of the microbiology, immunology, and clinical implications of Chlamydia trachomatis infections.

Authors:  M D Pearlman; S G McNeeley
Journal:  Obstet Gynecol Surv       Date:  1992-07       Impact factor: 2.347

3.  Evaluation of sequential testing strategies using non-amplified and amplified methods for detection of Chlamydia trachomatis in endocervical and urine specimens from women.

Authors:  Heather Semeniuk; Ali Zentner; Ron Read; Deirdre Church
Journal:  Diagn Microbiol Infect Dis       Date:  2002-01       Impact factor: 2.803

4.  Comparison of performance and cost-effectiveness of direct fluorescent-antibody, ligase chain reaction, and PCR assays for verification of chlamydial enzyme immunoassay results for populations with a low to moderate prevalence of Chlamydia trachomatis infection.

Authors:  D Dean; D Ferrero; M McCarthy
Journal:  J Clin Microbiol       Date:  1998-01       Impact factor: 5.948

Review 5.  Current methods of laboratory diagnosis of Chlamydia trachomatis infections.

Authors:  C M Black
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

6.  Predictors of Chlamydia trachomatis infection among female adolescents: a longitudinal analysis.

Authors:  D J Mosure; S Berman; D Kleinbaum; M E Halloran
Journal:  Am J Epidemiol       Date:  1996-11-15       Impact factor: 4.897

7.  Use of the polymerase chain reaction for the detection of Chlamydia trachomatis from endocervical and urine specimens in an asymptomatic low-prevalence population of women.

Authors:  M Skulnick; R Chua; A E Simor; D E Low; H E Khosid; S Fraser; E Lyons; E A Legere; D A Kitching
Journal:  Diagn Microbiol Infect Dis       Date:  1994-12       Impact factor: 2.803

8.  Periodic health examination, 1996 update: 2. Screening for chlamydial infections. Canadian Task Force on the Periodic Health Examination.

Authors:  H D Davies; E E Wang
Journal:  CMAJ       Date:  1996-06-01       Impact factor: 8.262

9.  Screening guidelines for Chlamydia trachomatis infection. Evaluating physician awareness, agreement, and use.

Authors:  K Weyman; A R Lanning
Journal:  Can Fam Physician       Date:  1995-02       Impact factor: 3.275

10.  Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection.

Authors:  D Scholes; A Stergachis; F E Heidrich; H Andrilla; K K Holmes; W E Stamm
Journal:  N Engl J Med       Date:  1996-05-23       Impact factor: 91.245

View more
  1 in total

1.  Chlamydia trachomatis infection in HIV-infected women: need for screening by a sensitive and specific test.

Authors:  Sonali Bhattar; Preena Bhalla; Sanjim Chadha; Reva Tripathi; Ravinder Kaur; Kabir Sardana
Journal:  Infect Dis Obstet Gynecol       Date:  2013-12-05
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.